Neurofibromatosis 1: Analysis of the demand for prenatal diagnosis in a French cohort of 361 patients
暂无分享,去创建一个
[1] J. Bernard,et al. Prenatal diagnosis of neurofibromatosis type 1: sonographic and MRI findings , 2006, Prenatal diagnosis.
[2] P. Devroey,et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. , 2005, Molecular human reproduction.
[3] K. Schoendorf,et al. Comparison of the use of amniocentesis in two countries with different policies for prenatal testing: the case of France and the United States , 2005, Prenatal diagnosis.
[4] H. Cuckle,et al. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. , 2004, Health technology assessment.
[5] F. Goffinet,et al. A population‐based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981–2000 , 2004, BJOG: an International Journal of Obstetrics and Gynaecology.
[6] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[7] K. Khosrotehrani,et al. Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients. , 2003, Journal of the American Academy of Dermatology.
[8] K. Khosrotehrani,et al. Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. , 2003, Archives of dermatology.
[9] A. Leplège,et al. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. , 2001, Archives of dermatology.
[10] T. Marteau,et al. Facilitating informed choice in prenatal testing: how well are we doing? , 2001, American journal of medical genetics.
[11] D. Coviello,et al. The Genoa experience of prenatal diagnosis in NF1 , 2000, Prenatal diagnosis.
[12] G Mortier,et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.
[13] J. Szudek,et al. Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children , 2000, Pediatrics.
[14] P. Nürnberg,et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.
[15] J. Friedman. Epidemiology of neurofibromatosis type 1. , 1999, American journal of medical genetics.
[16] H. Duivenvoorden,et al. Diagnostic delay in neurofibromatosis type 1 , 1997, European Journal of Pediatrics.
[17] X. Estivill,et al. Prenatal diagnosis of neurofibromatosis type 1: From flanking rflps to intragenic microsatellite markers , 1995, Prenatal diagnosis.
[18] I. Lerer,et al. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool. , 1994, American journal of medical genetics.
[19] D. Easton,et al. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.
[20] H. Kingston,et al. Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families. , 1993, Journal of medical genetics.
[21] A. Paller. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis , 1993 .
[22] J. Friedman,et al. National Neurofibromatosis Foundation International Database. , 1993, American journal of medical genetics.
[23] P. Harper,et al. Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1. , 1992, Journal of medical genetics.
[24] Amantadine , 1980, Annals of internal medicine.